Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study

References

• Ziaee M, Sharifzadeh G, Namaee MH, Fereidouni M. Prevalence of HIV and hepatitis B, C, D infections and their associated risk factors among prisoners in Southern Khorasan Province, Iran. Iran J Public Health. 2014;43(2):229.26060747
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Viral hepatitis surveillance—United States, 2009. Atlanta: Centers for Disease Control and Prevention. 2012:1–71. Available from: https://www.cdc.gov/hepatitis/statistics/2015surveillance/pdfs/2015HepSurveillanceRpt.pdf Accessed 920, 2019.
   Google Scholar
• Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei M, Saburi A. Seroprevalence and risk factors for hepatitis B in an adult population: the first report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9):e36452. doi:10.5812/hepatmon.3645227822260
   PubMed Web of Science ®Google Scholar
• Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330–9337. doi:10.3748/wjg.v20.i28.933025071327
   PubMed Web of Science ®Google Scholar
• Osmani F, Hajizadeh E, Mansoori P. Use of smoothing methods for estimating the coefficients of time dependent rate models in survival analysis and its application in psoriasis disease. Iran J Epidemiol. 2016;12(3):36–46.
   Google Scholar
• Moghaddasifar I, Lankarani KB, Moosazadeh M, et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplant Med. 2016;7(3):149–160.27721961
   PubMedGoogle Scholar
• Rastogi A, Sakhuja P, Kumar A, et al. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol. 2011;54(3):454–459. doi:10.4103/0377-4929.8507421934202
   PubMed Web of Science ®Google Scholar
• Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology. 2005;42:5–13. doi:10.1002/hep.2075015962320
   PubMed Web of Science ®Google Scholar
• Chen Y, Fan C, Chen Y, et al. Effect of hepatic steatosis on the progression of chronic hepatitis B: a prospective cohort and in vitro study. Oncotarget. 2017;8(35):58601–58610. doi:10.18632/oncotarget.1738028938582
   PubMedGoogle Scholar
• Alavian SM, Ramezani M, Bazzaz A, et al. Frequency of fatty liver and some of its risk factors in asymptomatic carriers of HBV attending the Tehran blood transfusion organization hepatitis clinic. Iran J Endocrinol Metab. 2008;10(2):99–106.
   Google Scholar
• Wong VW-S, Wong GL-H, Chu WC-W, et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol. 2012;56(3):533–540. doi:10.1016/j.jhep.2011.09.01322027575
   PubMed Web of Science ®Google Scholar
• Tsochatzis E, Papatheodoridis G, Manesis E, Chrysanthos N, Kafiri G, Archimandritis A. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis. 2007;39(10):936–942. doi:10.1016/j.dld.2007.07.15117720637
   PubMedGoogle Scholar
• Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005;43:38–44. doi:10.1016/j.jhep.2005.01.03115876468
   PubMed Web of Science ®Google Scholar
• Altlparmak E, Koklu S, Yalinkilic M. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol. 2005;11:3056–3059. doi:10.3748/wjg.v11.i20.305615918189
   PubMed Web of Science ®Google Scholar
• Thomopoulos KC, Arvaniti V, Tsamantas AC, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol. 2006;18:233–237. doi:10.1097/00042737-200603000-0000216462535
   PubMed Web of Science ®Google Scholar
• Bondini S, Kallman J, Wheeler A, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007;27:607. doi:10.1111/j.1478-3231.2007.01482.x17498244
   PubMed Web of Science ®Google Scholar
• Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6(3):161–163.17786142
   PubMed Web of Science ®Google Scholar
• Azarkar G, Zeinali T, Sharifzadeh G, Abedi F, Hajihosseini M, Ziaee M. Prevalence of non-alcoholic fatty liver and its related factors in Birjand, during year 2015. Mod Care J. 2016;13(4):e58829. doi:10.5812/mcj
   Google Scholar
• Ziaee M, Javanmard D, Sharifzadeh G, Namaei M, Azarkar G. Genotyping and mutation pattern in the overlapping MHR region of HBV isolates in Southern Khorasan, Eastern Iran. Hepat Mon. 2016;16(10):e37806. doi:10.5812/hepatmon27882062
   PubMed Web of Science ®Google Scholar
• Shi JP, Xun YH, Su YX, et al. Metabolic syndrome and severity of fibrosis in patients with chronic viral hepatitis B infection or non-alcoholic fatty liver disease. Afr J Microbiol Res. 2011;5(5):481–485.
   Google Scholar
• Lin YC, Hsiao ST, Chen JD. Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults. World J Gastroenterol. 2007;13(12):1805–1810. doi:10.3748/wjg.v13.i12.180517465470
   PubMed Web of Science ®Google Scholar
• Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know. World J Gastroenterol. 2014;20:12956–12980. doi:10.3748/wjg.v20.i36.1295625278691
   PubMed Web of Science ®Google Scholar
• Osmani F, Hajizadeh E, Rasekhi A. Association between multiple recurrent events with multivariate modeling: a retrospective cohort study. J Res Health Sci. 2018;18(4).
   Web of Science ®Google Scholar
• Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an update. World J Gastroenterol. 2014;20:9050.25083078
   PubMed Web of Science ®Google Scholar
• Lin C, Huang X, Liu H, Wang Y. Interactions of hepatitis B virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact. Dig Dis Sci. 2015;60(12):3513–3524. doi:10.1007/s10620-015-3772-z26112990
   PubMed Web of Science ®Google Scholar
• Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: fact or fiction? J Gastroenterol Hepatol. 2015;30:14–20. doi:10.1111/jgh.1270025092429
   PubMed Web of Science ®Google Scholar
• Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23:779–782. doi:10.1111/j.1440-1746.2007.05216.x18028349
   PubMed Web of Science ®Google Scholar
• Cheng YL, Wang YJ, Kao WY, et al. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One. 2013;8:e72049. doi:10.1371/journal.pone.007204923991037
   PubMed Web of Science ®Google Scholar
• Chiang CH, Yang HI, Jen CL, et al. Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond). 2013;37:410–415. doi:10.1038/ijo.2012.6322531094
   PubMed Web of Science ®Google Scholar
• Chen JY, Wang JH, Lin CY, et al. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. J Gastroenterol Hepatol. 2010;25. doi:10.1111/j.1440-1746.2010.06300.x
   Web of Science ®Google Scholar
• Razi B, Alizadeh S, Omidkhoda A, Imani D, Rezaei R. Association of chronic hepatitis B infection with metabolic syndrome and its components: meta‐analysis of observational studies. Diabetes Metab Syndr. 2017;11(Suppl 2):S939–S947. doi:10.1016/j.dsx.2017.07.02028701286
   PubMedGoogle Scholar
• Kuo YH, Kee KM, Wang JH, et al. Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study of 180 359 participants. Aliment Pharmacol Ther. 2018;48:993–1002. doi:10.1111/apt.1496030277595
   PubMed Web of Science ®Google Scholar
• Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology. 2017;65(3):828. doi:10.1002/hep.2891728035771
   PubMed Web of Science ®Google Scholar